Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR CSL Ltd (CSJ.MU) Follow Add holdings 132.78 -1.78 (-1.32%) At close: April 22 at 8:06:49 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for CSJ.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: CSJ.MU View More All News Press Releases SEC Filings Weekly Picks: 🧠 Alphabet’s AI edge, CSL’s pricing power, and a chip underdog Are CSL Limited's (ASX:CSL) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? BMRN vs. CSLLY: Which Stock Is the Better Value Option? CSL initiated with an Overweight at Morgan Stanley BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now? Only Two Days Left To Cash In On CSL's (ASX:CSL) Dividend Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia BMRN or CSLLY: Which Is the Better Value Stock Right Now? CSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) Here's What Analysts Are Forecasting For CSL Limited (ASX:CSL) After Its Half-Yearly Results European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine